P. Todd Korthuis, MD, MPH; Dennis McCarty, PhD; Melissa Weimer, DO, MCR; Christina Bougatsos, MPH; Ian Blazina, MPH; Bernadette Zakher, MBBS; Sara Grusing, BS; Beth Devine, PhD, PharmD, MBA; Roger Chou, MD
Disclaimer: The authors of this manuscript are responsible for its content. Statements in the manuscript should not be construed as endorsement by the AHRQ or the U.S. Department of Health and Human Services. The AHRQ retains a license to display, reproduce, and distribute the data and the report from which this manuscript was derived under the terms of the agency's contract with the author.
Financial Support: This project was funded under contract HHSA290201500009I, Task Order 4, from the AHRQ, U.S. Department of Health and Human Services.
Disclosures: Dr. McCarty reports research services agreements with Alkermes and Purdue Pharma outside the submitted work. Dr. Weimer reports personal fees from Indivior, the American Academy of Addiction Psychiatry, InforMED, and CODA outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-2149.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer and Johnson & Johnson.
Requests for Single Reprints: P. Todd Korthuis, MD, MPH, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code L-475, Portland, OR 97239-3098; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Korthuis and Weimer: Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code L-475, Portland, OR 97239-3098.
Dr. McCarty: OHSU-PSU School of Public Health, CB669, 3186 SW Sam Jackson Park Road, Portland, OR 97239.
Dr. Devine: University of Washington, Box 357630, Seattle, WA 98195-7630.
Ms. Bougatsos, Mr. Blazina, Drs. Zakher and Chou, and Ms. Grusing: Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code BICC, Portland, OR 97239.
Author Contributions: Conception and design: P.T. Korthuis, D. McCarty, M. Weimer, B. Devine, R. Chou.
Analysis and interpretation of the data: P.T. Korthuis, D. McCarty, M. Weimer, C. Bougatsos, B. Zakher, S. Grusing, R. Chou.
Drafting of the article: P.T. Korthuis, D. McCarty, C. Bougatsos, R. Chou.
Critical revision of the article for important intellectual content: P.T. Korthuis, D. McCarty, M. Weimer, I. Blazina, B. Zakher, B. Devine, R. Chou.
Final approval of the article: P.T. Korthuis, D. McCarty, M. Weimer, C. Bougatsos, I. Blazina, B. Zakher, S. Grusing, B. Devine, R. Chou.
Obtaining of funding: R. Chou.
Administrative, technical, or logistic support: C. Bougatsos, I. Blazina, S. Grusing.
Collection and assembly of data: P.T. Korthuis, D. McCarty, M. Weimer, C. Bougatsos, I. Blazina, B. Zakher, S. Grusing, R. Chou.
Greater integration of medication-assisted treatment (MAT) for opioid use disorder (OUD) in U.S. primary care settings would expand access to treatment for this condition. Models for integrating MAT into primary care vary in structure. This article summarizes findings of a technical report for the Agency for Healthcare Research and Quality describing MAT models of care for OUD, based on a literature review and interviews with key informants in the field. The report describes 12 representative models of care for integrating MAT into primary care settings that could be considered for adaptation across diverse health care settings. Common components of existing care models include pharmacotherapy with buprenorphine or naltrexone, provider and community education, coordination and integration of OUD treatment with other medical and psychological needs, and psychosocial services and interventions. Models vary in how each component is implemented. Decisions about adopting MAT models of care should be individualized to address the unique milieu of each implementation setting.
Table 1. Key Informants (n = 11)
Appendix Table 1. Sample Questions for Key Informants
Appendix Table 2. Search Strategies
Table 2. Sources for MAT Models of Care
Table 3. Overview of MAT Models of Care for OUD in the Primary Care Setting*
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Korthuis PT, McCarty D, Weimer M, et al. Primary Care–Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Ann Intern Med. 2017;166:268–278. [Epub ahead of print 6 December 2016]. doi: 10.7326/M16-2149
Download citation file:
Published: Ann Intern Med. 2017;166(4):268-278.
Published at www.annals.org on 6 December 2016
Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use